Jeff Fairman - 26 Oct 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
Jeff Fairman, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
26 Oct 2022
Transactions value $
-$400,000
Form type
4
Filing time
28 Oct 2022, 18:56:04 UTC
Previous filing
13 Oct 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale -$400,000 -10,000 -3.38% $40.00 286,227 26 Oct 2022 By Fairman Family Trust F1
holding PCVX Common Stock 17,143 26 Oct 2022 Direct
holding PCVX Common Stock 50,000 26 Oct 2022 By AF 2020 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.